Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00101348
Status:
COMPLETED
Last Update Posted:
2014-06-11
First Post:
2005-01-07
Brief Title:
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Colorectal Head and Neck Pancreatic or Non-Small Cell Lung Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Untreated Metastatic Squamous Neck Cancer With Occult Primary |
| Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma |
| Recurrent Adenoid Cystic Carcinoma of the Oral Cavity |
| Recurrent Basal Cell Carcinoma of the Lip |
| Recurrent Colon Cancer |
| Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity |
| Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity |
| Recurrent Lymphoepithelioma of the Nasopharynx |
| Recurrent Lymphoepithelioma of the Oropharynx |
| Recurrent Metastatic Squamous Neck Cancer With Occult Primary |
| Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity |
| Recurrent Mucoepidermoid Carcinoma of the Oral Cavity |
| Recurrent Non-small Cell Lung Cancer |
| Recurrent Pancreatic Cancer |
| Recurrent Rectal Cancer |
| Recurrent Salivary Gland Cancer |
| Recurrent Squamous Cell Carcinoma of the Hypopharynx |
| Recurrent Squamous Cell Carcinoma of the Larynx |
| Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity |
| Recurrent Squamous Cell Carcinoma of the Nasopharynx |
| Recurrent Squamous Cell Carcinoma of the Oropharynx |
| Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity |
| Recurrent Verrucous Carcinoma of the Larynx |
| Recurrent Verrucous Carcinoma of the Oral Cavity |
| Stage III Adenoid Cystic Carcinoma of the Oral Cavity |
| Stage III Basal Cell Carcinoma of the Lip |
| Stage III Colon Cancer |
| Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity |
| Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity |
| Stage III Lymphoepithelioma of the Nasopharynx |
| Stage III Lymphoepithelioma of the Oropharynx |
| Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity |
| Stage III Mucoepidermoid Carcinoma of the Oral Cavity |
| Stage III Pancreatic Cancer |
| Stage III Rectal Cancer |
| Stage III Salivary Gland Cancer |
| Stage III Squamous Cell Carcinoma of the Hypopharynx |
| Stage III Squamous Cell Carcinoma of the Larynx |
| Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity |
| Stage III Squamous Cell Carcinoma of the Nasopharynx |
| Stage III Squamous Cell Carcinoma of the Oropharynx |
| Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity |
| Stage III Verrucous Carcinoma of the Larynx |
| Stage III Verrucous Carcinoma of the Oral Cavity |
| Stage IIIB Non-small Cell Lung Cancer |
| Stage IV Adenoid Cystic Carcinoma of the Oral Cavity |
| Stage IV Basal Cell Carcinoma of the Lip |
| Stage IV Colon Cancer |
| Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity |
| Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity |
| Stage IV Lymphoepithelioma of the Nasopharynx |
| Stage IV Lymphoepithelioma of the Oropharynx |
| Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity |
| Stage IV Mucoepidermoid Carcinoma of the Oral Cavity |
| Stage IV Non-small Cell Lung Cancer |
| Stage IV Pancreatic Cancer |
| Stage IV Rectal Cancer |
| Stage IV Renal Cell Cancer |
| Stage IV Salivary Gland Cancer |
| Stage IV Squamous Cell Carcinoma of the Hypopharynx |
| Stage IV Squamous Cell Carcinoma of the Larynx |
| Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity |
| Stage IV Squamous Cell Carcinoma of the Nasopharynx |
| Stage IV Squamous Cell Carcinoma of the Oropharynx |
| Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity |
| Stage IV Verrucous Carcinoma of the Larynx |
| Stage IV Verrucous Carcinoma of the Oral Cavity |
Keywords: